We are live on ! Find out more
CIM

Contravisory Investment Management Portfolio holdings

AUM $566M
1-Year Est. Return 42.93%
This Fund
S&P 500
This Quarter Est. Return
+21.72%
1 Year Est. Return
+42.93%
3 Year Est. Return
+129.34%
5 Year Est. Return
+198.47%
10 Year Est. Return
+603.03%
AUM
$272M
AUM Growth
+$46.5M
Cap. Flow
+$9.18M
Cap. Flow %
3.37%
Top 10 Hldgs %
26.6%
Holding
346
New
62
Increased
72
Reduced
60
Closed
95

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$5.92M
2
SPGI icon
S&P Global
SPGI
+$4.98M
3
AMZN icon
Amazon
AMZN
+$4.9M
4
CAH icon
Cardinal Health
CAH
+$4.73M
5
CHE icon
Chemed
CHE
+$4.63M

Top Sells

Rank Stock Value
1
CTAS icon
Cintas
CTAS
+$6.44M
2
MAA icon
Mid-America Apartment Communities
MAA
+$4.56M
3
HON icon
Honeywell
HON
+$4.16M
4
ROST icon
Ross Stores
ROST
+$4.03M
5
LSI
Life Storage, Inc.
LSI
+$3.83M

Sector Composition

Rank Sector Weight
1 Technology 23.4%
2 Healthcare 18.72%
3 Financials 12.56%
4 Consumer Staples 11.35%
5 Industrials 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNPS icon
1
Synopsys
SNPS
$76.8B
$9.84M 3.62%
52,874
-2,159
-4% -$356K
MSFT icon
2
Microsoft
MSFT
$2.95T
$8.26M 3.04%
42,669
-1,341
-3% -$243K
ZBRA icon
3
Zebra Technologies
ZBRA
$12.8B
$7.88M 2.9%
29,573
+961
+3% +$225K
ACN icon
4
Accenture
ACN
$98.1B
$7.39M 2.72%
36,149
-245
-0.7% -$46.3K
PYPL icon
5
PayPal
PYPL
$50.9B
$7.32M 2.69%
45,422
+28
+0.1% +$3.87K
GRMN
6
Garmin
GRMN
$47.7B
$7.02M 2.58%
73,855
-418
-0.6% -$35.7K
ABBV icon
7
AbbVie
ABBV
$464B
$6.52M 2.4%
67,895
+67,245
+10,345% +$5.92M
TMO icon
8
Thermo Fisher Scientific
TMO
$215B
$6.12M 2.25%
17,622
+66
+0.4% +$22.1K
V icon
9
Visa
V
$693B
$6.07M 2.23%
31,447
+636
+2% +$116K
MCK icon
10
McKesson
MCK
$102B
$5.96M 2.19%
38,139
+1,964
+5% +$284K
KMB icon
11
Kimberly-Clark
KMB
$38.1B
$5.92M 2.18%
42,081
-293
-0.7% -$40.4K
ABT icon
12
Abbott
ABT
$186B
$5.91M 2.17%
65,898
+1,731
+3% +$156K
AON icon
13
Aon
AON
$80.2B
$5.78M 2.13%
31,072
+739
+2% +$138K
RSG icon
14
Republic Services
RSG
$67.8B
$5.72M 2.1%
69,136
-405
-0.6% -$32.7K
TMUS icon
15
T-Mobile US
TMUS
$198B
$5.63M 2.07%
54,757
+2,250
+4% +$216K
SPGI icon
16
S&P Global
SPGI
$122B
$5.53M 2.03%
17,019
+16,564
+3,640% +$4.98M
NEE icon
17
NextEra Energy
NEE
$187B
$5.5M 2.02%
88,608
+960
+1% +$57.5K
AMZN icon
18
Amazon
AMZN
$2.48T
$5.47M 2.01%
41,820
+40,560
+3,219% +$4.9M
ADBE icon
19
Adobe
ADBE
$97.8B
$5.46M 2.01%
13,253
-68
-0.5% -$25.2K
LMT icon
20
Lockheed Martin
LMT
$135B
$5.39M 1.98%
14,089
+165
+1% +$62.3K
GOOG icon
21
Alphabet (Google) Class C
GOOG
$4.01T
$5.36M 1.97%
74,300
+1,280
+2% +$86.4K
ZTS icon
22
Zoetis
ZTS
$33.2B
$5.35M 1.97%
39,273
+553
+1% +$72.2K
CAH icon
23
Cardinal Health
CAH
$54.3B
$5M 1.84%
+91,819
New +$4.73M
CPB icon
24
Campbell Soup
CPB
$6.86B
$4.92M 1.81%
100,112
-143
-0.1% -$7.1K
COST icon
25
Costco
COST
$433B
$4.91M 1.81%
16,298
+412
+3% +$125K
1
2 3 4 5

Similar funds

SAM
Satovsky Asset Management New York $566M AUM 15.8% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
KJWM
Kiley Juergens Wealth Management Olympia, Washington $567M AUM 27.42% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return
PEP
Providence Equity Partners Providence, Rhode Island $565M AUM 37.52% 1-Year Est. Return
OC
Opal Capital Boca Raton, Florida $565M AUM
LC
Lavaca Capital Houston, Texas $564M AUM 4.6% 1-Year Est. Return
BRIM
Broad Run Investment Management Arlington, Virginia $568M AUM 50.18% 1-Year Est. Return

Contravisory Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, Contravisory Investment Management held 346 positions worth $272M, up 21% from $226M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Contravisory Investment Management deployed $9.18M of net new capital in Q2 2020, opening 62 new positions and adding to 72 existing holdings. Its largest new stake was Cardinal Health: 91,819 shares worth $5M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Walt Disney, an estimated $3.62M trimmed.

  • Contravisory Investment Management's largest Q2 2020 buy was Cardinal Health: 91,819 shares worth $5M.
  • Contravisory Investment Management added most to AbbVie in Q2 2020, an estimated $5.92M increase.
  • Contravisory Investment Management's biggest Q2 2020 reduction was Walt Disney, cutting an estimated $3.62M.
  • Contravisory Investment Management fully exited Cintas in Q2 2020, selling an estimated $6.44M.
  • Contravisory Investment Management's ten largest holdings make up 27% of its $272M portfolio in Q2 2020.
  • Contravisory Investment Management opened 62 new positions and closed 95 in Q2 2020.
  • Contravisory Investment Management's portfolio value rose 21% quarter-over-quarter to $272M.

Based on Contravisory Investment Management's 13F filing for Q2 2020, filed 9 Jul 2020.